Use fundamental data analysis to double-check all available reported financial drivers of Bharat Immunologicals to find out if markets are presently mispricing the company. We found twenty-two available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Bharat Immunologicals to be traded at 35.34 in 30 days
Bharat Immunologicals Company SummaryBharat Immunologicals competes with Reliance Industries, Tata Consultancy, Tata Consultancy, HDFC Bank, and HDFC BANK. Bharat Immunologicals Biologicals Corp Ltd offers oral polio vaccines diarrhea management kits for the management of diarrhea in young children zinc dispersible tablets and iron folic acid tablets for the treatment of iron deficiency and iron deficiency anemia. Bharat Immunologicals and Biologicals Corporationration Limited was founded in 1989 and is based in Bulandshahr India.
Bharat Immunologicals Return On Asset vs Debt to Equity
Bharat Immunologicals Biologicals Corp Ltd is rated below average in return on asset category among related companies. It is number one stock in debt to equity category among related companies .